Methohexital Sodium Injection
NDC Package 83270-003-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Methohexital Sodium injection is methohexital Sodium for Injection can be used in adults as follows:• 1.For intravenousinduction of anesthesia prior to the use of other general anesthetic agents. This formulation utilizes a injection delivery system. Marketed by Onesource Specialty Pharma Limited, this product is identified by NDC 83270-003 and is authorized under FDA application ANDA215488.

Identification & Billing

NDC Package Code
83270-003-01
Package Description
500 mg in 1 VIAL
Product Code
83270-003
11-Digit Billing Format
83270000301
RxNorm Crosswalk
  • RxCUI: 1244233 - methohexital sodium Variable Concentration Multi-Use Injectable Solution
  • RxCUI: 1244233 - methohexital sodium 50 MG/ML Injectable Solution

Clinical Specifications

Proprietary Name
Methohexital Sodium
Non-Proprietary Name
Methohexital Sodium
Substance Name
Methohexital Sodium
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
METHOHEXITAL SODIUM 500 mg/500mg
Pharmacologic Class
Usage Information
Methohexital Sodium for Injection can be used in adults as follows:• 1.For intravenousinduction of anesthesia prior to the use of other general anesthetic agents. • 2.For intravenousinduction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; Methohexital Sodium for Injection may be given by infusion or intermittent injection. • 3.For use along with other parenteral agents, usually narcotic analgesics, to supplement subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for longer surgical procedures.• 4.As intravenousanesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli (see WARNINGS). • 5.As an agent for inducing a hypnotic state.Methohexital Sodium for Injection can be used in pediatric  patients older than 1 monthas follows: • 1.For rectal or intramuscularinduction of anesthesia prior to the use of other general anesthetic agents.   2.For rectal or intramuscularinduction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents for short surgical procedures. • 3.As rectal or intramuscularanesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli.
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Onesource Specialty Pharma Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA215488
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-24-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83270-003-01 identifies a specific commercial package of 500 mg in 1 vial of Methohexital Sodium, a human prescription drug labeled by Onesource Specialty Pharma Limited. This injection is formulated for intravenous use and contains methohexital sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Onesource Specialty Pharma Limited on January 24, 2026. The current certification is valid through December 31, 2027.

How is this Onesource Specialty Pharma Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83270000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83270-003-01
11-Digit CMS (5-4-2)
83270-0003-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.